VistaGen nabs phase 3-ready social anxiety drug from Pherin | Digital…
VistaGen Therapeutics has licensed Pherin Pharmaceuticals’ lead candidate, a phase 3-ready treatment for social anxiety disorder (SAD). Under the deal,…
Browsing Tag
Nano Tech
A very special protein synthesis machinery | Digital Science
Ribosomes are among the most important molecular machines within the cell that hardly changed in the course of evolution. Their function is to read copies of…
New genetics tool helps answer evolutionary questions | Digital Science
Thanks to Gideon Bradburd, MSU population geneticist, scientists have a new tool for their modern genomic toolbox. Credit: Derrick Turner
The age of big…
Amgen to consolidate its digital patient engagement systems under Deloitte…
Amgen has tapped Deloitte to build the foundation of its global digital patient services strategy. Deloitte will use its cloud-based ConvergeHEALTH Patient…
Gilead taps gene editors at Precision BioSciences for hep B cure…
Gilead Sciences is pursuing a new avenue toward hepatitis B treatment, collaborating on gene therapies aimed at eliminating viral infections in vivo by using…
Atreca bags $125M as solid tumor trial comes into view | Digital Science
Atreca has raised $125 million to step up its R&D activities. The series C round comes as Atreca gears up to move its lead solid tumor drug into the clinic…
DNA accessibility, gene expression jointly profiled in thousands of cells |…
Scientists have now developed an assay that concurrently profiles both the epigenome and transcriptome of each of thousands of single cells. The epigenome and…
OncoResponse raises $40M for cancer patient-sourced antibodies | Digital…
Texas biotech OncoResponse has raised $40 million in second-round financing to develop drugs based on antibodies taken from cancer survivors. The…
Parexel debuts its Patient Innovation Center aiming for improved biopharma…
Global CRO Parexel debuted its Patient Innovation Center that is designed to boost efficiency and success across the board for biopharmaceutical development.…
Guardant Health discloses cyberattack alongside planned IPO | Digital…
In an SEC filing for its initial public offering, Guardant Health disclosed that it had been the victim of a cyberattack earlier this summer, with hackers…